Submitted by Anonymous (not verified) on 28 January 2026 - 14:44
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 14, Status: Authorised